OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
Lizhuo Zhang, Qingqing Feng, Jiafeng Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188928-188928
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Advances in Radioligand Theranostics in Oncology
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11

Update on current diagnosis and management of anaplastic thyroid carcinoma
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 570-583
Open Access | Times Cited: 12

Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study
Hong Sun, Ling Li, Jingchao Yan, et al.
Endocrine (2024) Vol. 86, Iss. 2, pp. 732-743
Closed Access | Times Cited: 4

Diagnosis and treatment of a rare bilateral primary thyroid cancer: a case report
Hai Lin, Xinyu Zhang, Na Yan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access

A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer
Yefeng Cai, Yawen Guo, Wenli Ma, et al.
European Journal of Endocrinology (2025) Vol. 192, Iss. 2, pp. 128-140
Closed Access

The potential mechanisms by which Xiaoyao Powder may exert therapeutic effects on thyroid cancer were examined at various levels
Xiaoli Lei, Feifei Wang, Xinying Zhang, et al.
Computational Biology and Chemistry (2025) Vol. 117, pp. 108412-108412
Closed Access

A rare case of rib chondrosarcoma with purely mesenchymal cells metastases to thyroid
Jia Wang, Fang Mei, Mingcheng Li, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access

Effect of radioactive iodine therapy on hematological parameters in patients with thyroid cancer: systematic review and meta-analysis
Dereje Mengesha Berta, Bisrat Birke Teketelew, Negesse Cherie, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer
Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, et al.
Advanced Science (2025)
Open Access

PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access

Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3

Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy
Shunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4336-4346
Closed Access | Times Cited: 3

ENO2 promotes anoikis resistance in anaplastic thyroid cancer by maintaining redox homeostasis
Yu Zhang, Xiaoyu Ji, Yu Wang
Gland Surgery (2024) Vol. 13, Iss. 2, pp. 209-224
Open Access | Times Cited: 2

Identification and clinical value of a new ceRNA axis (TIMP3/hsa‐miR‐181b‐5p/PAX8‐AS1) in thyroid cancer
Jiamin Liang, Yu Deng, Yubi Zhang, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 1

Predictive biomarkers in thyroid cancer in the current molecular-morphology paradigm
Humberto Carneiro, Rodrigo de Andrade Natal, Evelin Cavalcante Farias, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Medullary thyroid cancer: single-cell transcriptome and tumor evolution
Lifeng Wang, Wen-Wen Zhou, Yuan Fang, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1

Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma
Yang Xie, Junqi Xiao, Yong Ying, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5663-5676
Closed Access

Editorial for the Special Issue “Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design”
C. Aprile, Onelio Geatti, Letizia Canziani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2398-2401
Open Access

The Effects of Tetrahydrocurcumin on Adriamycin and Taxane resistance in Anaplastic Thyroid Cancer Cells
Mehmet Ali Koçdor, Yagmur Kaya, Halil Ateş, et al.
Research Square (Research Square) (2024)
Open Access

Molecular genetic markers of highly differentiated thyroid cancer (literature review and personal observations)
О. Yu. Usenko, І. П. Хоменко, Kovalenko Ae, et al.
The Ukrainian Journal of Clinical Surgery (2024) Vol. 90, Iss. 6, pp. 23-34
Open Access

Page 1 - Next Page

Scroll to top